Ivan Gergel

Verified

Managing Partner & Chief Medical Officer at New Rhein Healthcare InvestorsListed on SEC Form ADVPhiladelphia, United States

Claim this profile

Cool

Check Size

Not yet known

Reliability Score

🎯100% of deals in Healthcare

Investment Timeline

Alveus Therapeutics

Board seat (SEC Form D)Source

Since Jan 2026

Company last raised Jan 2026

Neuraptive Therapeutics

Board seat (SEC Form D)Source

Since Apr 2019

Company last raised Oct 2022

Portfolio Breakdown

By Sector

Healthcare2 deals · 100%

By Stage

2 tracked deals1 sector · 0 stages

Deal Velocity

Avg Deals / Year

0.3

Avg Deal Size

Unknown

Largest Deal

Alveus Therapeutics

Unknown

YoY Trend

Accelerating

Deals Per Year

2 total deals tracked2019–2026

Investment Activity Map

Jan

Feb

Mar

Apr

May

Jun

Jul

Aug

Sep

Oct

Nov

Dec

2019

2020

2021

2022

2023

2024

2025

2026

Less

Current Fund Status

Fund Name

New Rhein Healthcare 18 (parallel) Scsp

Reported Size

$26.4M

Co-Investors

No co-investment data available yet.